BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11511294)

  • 41. Xeroderma pigmentosum in a Malaysian child with identification of a novel homozygous nonsense mutation in XPC c.2167C>T.
    Albela H; Ngu LH; Leong KF
    Int J Dermatol; 2022 Sep; 61(9):e324-e326. PubMed ID: 35235204
    [No Abstract]   [Full Text] [Related]  

  • 42. No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma.
    Blankenburg S; König IR; Moessner R; Laspe P; Thoms KM; Krueger U; Khan SG; Westphal G; Volkenandt M; Neumann C; Ziegler A; Kraemer KH; Reich K; Emmert S
    Eur J Hum Genet; 2005 Feb; 13(2):253-5. PubMed ID: 15494739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA repair-related heritable photosensitivity syndromes: Mutation landscape in a multiethnic cohort of 17 multigenerational families with high degree of consanguinity.
    Hozhabrpour A; Mojbafan M; Palizban F; Vahidnezhad F; Talebi S; Amani M; Garshasbi M; Naghavi A; Khalesi R; Mansouri P; Sotoudeh S; Mahmoudi H; Varghaei A; Daneshpazhooh M; Karimi F; Zeinali S; Kalamati E; Uitto J; Youssefian L; Vahidnezhad H
    DNA Repair (Amst); 2024 Apr; 136():103633. PubMed ID: 38422792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA-based prenatal diagnosis in a Chinese family with xeroderma pigmentosum group A.
    Yang Y; Ding B; Wang K; Bu D; Tu P; Zhu X
    Br J Dermatol; 2004 Jun; 150(6):1190-3. PubMed ID: 15214909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of risk of squamous cell carcinoma head and neck in North Indian population with polymorphisms in xeroderma pigmentosum complementation Group C gene.
    Yadav SK; Singh S; Gupta S; Brahma Bhatt ML; Mishra DP; Roy D; Sanyal S
    J Cancer Res Ther; 2018; 14(3):651-657. PubMed ID: 29893334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function.
    Khan SG; Muniz-Medina V; Shahlavi T; Baker CC; Inui H; Ueda T; Emmert S; Schneider TD; Kraemer KH
    Nucleic Acids Res; 2002 Aug; 30(16):3624-31. PubMed ID: 12177305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease.
    Dupuy A; Sarasin A
    Mutat Res; 2015 Jun; 776():2-8. PubMed ID: 26255934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
    Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
    J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
    Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
    Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultraviolet B radiation-induced skin cancer in mice defective in the Xpc, Trp53, and Apex (HAP1) genes: genotype-specific effects on cancer predisposition and pathology of tumors.
    Cheo DL; Meira LB; Burns DK; Reis AM; Issac T; Friedberg EC
    Cancer Res; 2000 Mar; 60(6):1580-4. PubMed ID: 10749126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
    Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Three nonsense mutations responsible for group A xeroderma pigmentosum.
    Satokata I; Tanaka K; Miura N; Narita M; Mimaki T; Satoh Y; Kondo S; Okada Y
    Mutat Res; 1992 Mar; 273(2):193-202. PubMed ID: 1372102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of Function Variants in the XPC Causes Severe Xeroderma Pigmentosum in Three Large Consanguineous Families.
    Nawal W; Ullah A; Ullah U; Farrakh K; Ahmad F; Khan H; Ahmad GS; Khan B; Ansar M; Kalsoom UE; Ahmad W
    Klin Padiatr; 2022 May; 234(3):123-129. PubMed ID: 34544175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel frameshift mutation in the XPC gene in a Moroccan patient: a case report.
    Doubaj Y; Smaili W; Laarabi FZ; Sefiani A
    J Med Case Rep; 2017 Jun; 11(1):158. PubMed ID: 28615033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Compound heterozygosity for the Xeroderma pigmentosum complementation group A gene associated with a mild phenotype.
    Negishi I; Kato G; Moriwaki S; Ishikawa O
    Eur J Dermatol; 2002; 12(6):536-9. PubMed ID: 12459522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severe neurological abnormalities associated with a mutation in the zinc-finger domain in a group A xeroderma pigmentosum patient.
    Maeda T; Sato K; Minami H; Taguchi H; Yoshikawa K
    Br J Dermatol; 1994 Oct; 131(4):566-70. PubMed ID: 7947212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel splice variant of the DNA-PKcs gene is associated with clinical and cellular radiosensitivity in a patient with xeroderma pigmentosum.
    Abbaszadeh F; Clingen PH; Arlett CF; Plowman PN; Bourton EC; Themis M; Makarov EM; Newbold RF; Green MH; Parris CN
    J Med Genet; 2010 Mar; 47(3):176-81. PubMed ID: 19797196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and cellular ionizing radiation sensitivity in a patient with xeroderma pigmentosum.
    Arlett CF; Plowman PN; Rogers PB; Parris CN; Abbaszadeh F; Green MH; McMillan TJ; Bush C; Foray N; Lehmann AR
    Br J Radiol; 2006 Jun; 79(942):510-7. PubMed ID: 16714754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. c.1643_1644delTG XPC mutation is more frequent in Moroccan patients with xeroderma pigmentosum.
    Senhaji MA; Abidi O; Nadifi S; Benchikhi H; Khadir K; Ben Rekaya M; Eloualid A; Messaoud O; Abdelhak S; Barakat A
    Arch Dermatol Res; 2013 Jan; 305(1):53-57. PubMed ID: 23143338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
    Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H
    Cancer Res; 2008 Mar; 68(5):1347-53. PubMed ID: 18316597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.